Outcomes following cryoablation of stage IA non-small cell lung cancer in patients with and without interstitial lung disease: A retrospective single-center cohort study

医学 不良事件通用术语标准 低温消融 回顾性队列研究 阶段(地层学) 累积发病率 间质性肺病 四分位间距 肺癌 不利影响 危险系数 队列 外科 内科学 置信区间 烧蚀 古生物学 生物
作者
Jonathan A. Sänger,Alexander Graur,Ismail Tahir,Melissa C. Price,Florence K. Keane,Michael Lanuti,Amita Sharma,Florian J. Fintelmann
出处
期刊:Lung Cancer [Elsevier BV]
卷期号:181: 107231-107231 被引量:10
标识
DOI:10.1016/j.lungcan.2023.107231
摘要

To compare the safety and efficacy of cryoablation of treatment-naïve stage IA non-small cell lung cancer (NSCLC) in patients with and without interstitial lung disease (ILD).This retrospective single-center cohort study evaluated 33 consecutive patients (24 females, median age 75 years, Eastern Cooperative Oncology Group performance score 0-3) with ILD (9 patients) and without ILD (24 patients) who underwent 39 percutaneous cryoablations to treat 42 stage IA (8th IASLC edition) NSCLC measuring 1.2 cm (range 0.5-2.6 cm) from 2018 to 2022. Presence of ILD was determined according to 2018 American Thoracic Society Criteria on pre-ablation CT scans. The primary outcome was 90-day adverse events graded by the Common Terminology Criteria for Adverse Events (CTCAE) v5.0. Secondary outcomes were hospital length of stay (LOS), local recurrence-free survival, overall survival, and the cumulative incidence of local recurrence with death as a competing risk.Adverse events ranged from grade 1-3 and occurred more often in the non-ILD group (p <.001). No acute exacerbation of ILD or death occurred within 90 days after cryoablation. The median LOS was 1 day (interquartile range 1-2 days) and did not differ between groups. One patient with ILD and two patients without ILD died after 22, 26, and 27 months from causes unrelated to cryoablation. Median imaging follow-up was 11 months (range, 0-47 months) and three tumors (7%) showed local recurrence after 4, 17, and 22 months. No difference in the cumulative incidence of local recurrence (p =.56) was found. Among all patients, local recurrence-free survival on a per-tumor basis and overall survival were 97% and 100% at 1 year, respectively.Adverse events and local recurrence following percutaneous cryoablation of stage IA NSCLC did not differ between patients with and without ILD. No acute exacerbation of ILD or death within 90 days were observed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
拾壹完成签到,获得积分10
6秒前
雪花完成签到,获得积分10
8秒前
清风完成签到 ,获得积分10
8秒前
雪花发布了新的文献求助10
12秒前
秀丽笑容完成签到 ,获得积分10
16秒前
江湖应助聪慧芷巧采纳,获得10
17秒前
量子星尘发布了新的文献求助10
18秒前
Rjy完成签到 ,获得积分10
24秒前
性感母蟑螂完成签到 ,获得积分10
30秒前
ruochenzu完成签到,获得积分10
32秒前
陈尹蓝完成签到 ,获得积分10
33秒前
天道酬勤完成签到,获得积分10
35秒前
37秒前
仁爱的谷南完成签到,获得积分10
37秒前
雯雯完成签到 ,获得积分10
39秒前
一路有你完成签到 ,获得积分10
39秒前
40秒前
ruochenzu发布了新的文献求助10
40秒前
42秒前
wanghao完成签到 ,获得积分10
43秒前
图图发布了新的文献求助10
43秒前
十三完成签到 ,获得积分10
43秒前
聪慧芷巧完成签到,获得积分10
44秒前
米博士完成签到,获得积分10
45秒前
研友_VZGVzn完成签到,获得积分10
46秒前
Cheung2121发布了新的文献求助30
47秒前
黄芩完成签到 ,获得积分10
48秒前
1分钟前
秋半梦完成签到,获得积分10
1分钟前
李爱国应助科研通管家采纳,获得10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
搜集达人应助科研通管家采纳,获得10
1分钟前
打地鼠工人完成签到,获得积分10
1分钟前
彩色半烟完成签到,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
Ning完成签到,获得积分10
1分钟前
图图完成签到,获得积分10
1分钟前
勤奋的灯完成签到 ,获得积分10
1分钟前
ludong_0完成签到,获得积分10
1分钟前
Asumita完成签到,获得积分10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038066
求助须知:如何正确求助?哪些是违规求助? 3575779
关于积分的说明 11373801
捐赠科研通 3305584
什么是DOI,文献DOI怎么找? 1819239
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022